Although IL-33 activated eosinophils released higher quantities of EV, our on chip and transwell experiments with Bodipy FL C16-labelled mouse eosinophils indicate that both Eo5-EV and Eo33-EV were efficiently integrated into target tumor cells. Here, IL33 is linked to neoplasm.